Wright Medical Group Inc  

(Public, NASDAQ:WMGI)   Watch this stock  
Find more results for WMGI
26.59
May 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 23.56 - 32.65
Open     -
Vol / Avg. 0.00/823,810.00
Mkt cap 1.37B
P/E     -
Div/yield     -
EPS -5.09
Shares 51.40M
Beta 0.52
Inst. own 121%
Jul 29, 2015
Q2 2015 Wright Medical Group Inc Earnings Call - 4:30PM EDT - Add to calendar
Jul 29, 2015
Q2 2015 Wright Medical Group Inc Earnings Release - Tentative Add to calendar
Jun 18, 2015
Wright Medical Group Inc Extraordinary Shareholders Meeting - 11:00AM EDT - Add to calendar
Jun 2, 2015
Wright Medical Group Inc at Jefferies Global Healthcare Conference - 8:30AM EDT - Add to calendar
Apr 29, 2015
Q1 2015 Wright Medical Group Inc Earnings Call - Webcast
Apr 29, 2015
Q1 2015 Wright Medical Group Inc Earnings Release
Mar 12, 2015
Wright Medical Group Inc at Barclays Healthcare Conference
Feb 25, 2015
Q4 2014 Wright Medical Group Inc Earnings Call - Webcast
Feb 25, 2015
Q4 2014 Wright Medical Group Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -59.34% -80.70%
Operating margin -42.50% -33.49%
EBITD margin - -17.18%
Return on average assets -17.72% -25.31%
Return on average equity -70.55% -65.13%
Employees 1,180 -
CDP Score - -

Address

5677 Airline Rd
ARLINGTON, TN 38002-9501
United States - Map
+1-901-8679971 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Wright Medical Group, Inc. is a global orthopedic company. The Company operates through its subsidiary Wright Medical Technology, Inc. and others. The Company provides extremity and biologic solutions that enable clinicians to alleviate pain and restore their patients’ lifestyles. The company also provides surgical solutions for the foot and ankle market. The Company’s business includes products that are used in foot and ankle repair, upper extremity products and biologics products, which are used to replace damaged or diseased bone, to stimulate bone growth and to provide other biological solutions for surgeons and their patients. The Company markets its products in over 60 countries across the world.

Officers and directors

David D. Stevens Independent Chairman of the Board
Age: 62
Bio & Compensation  - Reuters
Robert J. Palmisano President, Chief Executive Officer, Director
Age: 69
Bio & Compensation  - Reuters
Lance A. Berry Chief Financial Officer, Senior Vice President
Age: 41
Bio & Compensation  - Reuters
Kevin D. Cordell President - U.S. Extremities
Age: 48
Bio & Compensation  - Reuters
Pascal E.R. Girin Chief Operating Officer, Executive Vice President
Age: 55
Bio & Compensation  - Reuters
Jason R. Senner Chief Human Resource Officer, Senior Vice President
Age: 47
Bio & Compensation  - Reuters
Daniel J. Garen Senior Vice President, Chief Compliance Officer
Age: 41
Bio & Compensation  - Reuters
James A. Lightman Senior Vice President, General Counsel, Secretary
Age: 56
Bio & Compensation  - Reuters
Julie D. Tracy Senior Vice President, Chief Communications Officer
Age: 51
Bio & Compensation  - Reuters
Peter Cooke Senior Vice President - International
Age: 48
Bio & Compensation  - Reuters